Purple Innovation reported a net revenue decline of 12.6% to $105.1 million in Q2 2025, primarily due to delays in Rejuvenate 2.0 shipments, wholesale door count reductions, and softness in e-commerce. Despite this, the company's net loss was $(17.3) million, and adjusted EBITDA improved to $(2.4) million from $(4.1) million in the prior year, driven by disciplined cost management.
Second quarter 2025 net revenue decreased by 12.6% to $105.1 million compared to $120.3 million in Q2 2024.
Gross profit for the second quarter was $37.7 million, down from $48.9 million in the prior-year period, with gross margin at 35.9%.
Operating expenses decreased by 18.2% to $51.9 million, largely due to reduced advertising spend and cost savings initiatives.
Net loss attributable to Purple Innovation, Inc. for the second quarter was $(17.3) million, a decline from $0.0 in the prior year.
Purple Innovation is reiterating its full-year 2025 outlook, expecting revenue between $465 million and $485 million and adjusted EBITDA ranging from flat to positive $10 million. The company anticipates sequential growth in the second half of the year, driven by the Rejuvenate 2.0 launch and the expanded partnership with Mattress Firm.
Analyze how earnings announcements historically affect stock price performance